Alzheimer’s dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland. Swiss Med Wkly [Internet]. 2012 Nov. 18 [cited 2025 Nov. 23];142(4748):w13676. Available from: https://smw.ch/index.php/smw/article/view/1621